Naoki Okamura
Pharma

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

With Xtandi set to lose U.S. patent protection next year, Astellas’ CEO fielded questions this week about his company’s BD strategy ahead of the loss.
Angus Liu Jan 15, 2026 10:42am
FDA

FDA proposes flu shot labels include warnings for febrile seizures

Jan 15, 2026 12:07pm
FDA

2025 approvals: Biopharma delivered 55 new drugs, biologics

Brought to you by Real Chemistry
President Trump speaks in the Oval Office
Favicon Fierce Healthcare

Trump targets insurers, drug prices in 'Great Healthcare Plan'

Jan 15, 2026 11:51am
Abstract purple and magenta ribbon-like design layered over a collage of black-and-white portraits of Fierce 50 honorees in h

Fierce 50 of 2025

Brought to you by Finn Partners
BeOne Medicines Brukinsa TV ad

FDA chides BeOne, ImmunityBio in separate untitled letters

Jan 15, 2026 11:50am
More News

Johnson & Johnson's Tecvayli struts its stuff as a monotherapy

Jan 15, 2026 10:15am

Hologic sets a screen to block cervical cancer with WNBA star

Jan 15, 2026 10:00am

JPM26, Day 3: AbbVie, AZ, Novo execs share visions for ’26

Jan 14, 2026 2:29pm
Fierce Biotech

JPM26: Sanofi looks ahead to lingering US policy hurdles

Jan 14, 2026 2:28pm